Motion Sickness Clinical Trial
Official title:
Motion Serifos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel
A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in participants affected by motion sickness during travel
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
Recruiting |
NCT06128707 -
Vestibulo-Ocular Reflex Function in Individuals With Chronic Motion Sensitivity Cross-Sectional Study
|
||
Completed |
NCT05611814 -
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
|
N/A | |
Recruiting |
NCT06106256 -
Three-Axis Wearable Adaptive Vestibular Stimulator
|
N/A | |
Completed |
NCT02839135 -
A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.
|
Phase 1 | |
Completed |
NCT04420949 -
Sensory Training for Visual Motion Sickness
|
N/A | |
Completed |
NCT04184115 -
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
|
Phase 3 | |
Completed |
NCT03988530 -
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
|
Phase 3 | |
Terminated |
NCT04219982 -
DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
|
Phase 2/Phase 3 | |
Terminated |
NCT02155309 -
Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray
|
Phase 2/Phase 3 | |
Completed |
NCT04947423 -
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
|
Phase 3 | |
Recruiting |
NCT04999449 -
Nebulizer Delivery of Intranasal Scopolamine
|
Phase 1 | |
Recruiting |
NCT05886660 -
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
|
Phase 2 | |
Completed |
NCT03755596 -
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness
|
Phase 4 | |
Recruiting |
NCT05628220 -
Motion Sickness Desensitization Using VR
|
N/A | |
Recruiting |
NCT06138613 -
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
|
Phase 3 | |
Completed |
NCT04327661 -
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
|
Phase 3 | |
Completed |
NCT06232785 -
Gynecologic Endoscopic Surgery of Female Motion Sickness Patients
|
Phase 4 | |
Completed |
NCT06056622 -
Motion Sickness Rehabilitation for Virtual Reality
|
N/A | |
Withdrawn |
NCT04331561 -
Sensory Training for Orientation and Balance
|
N/A |